Know Cancer

or
forgot password

Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET


N/A
18 Years
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET


Inclusion Criteria:



- Histologically confirmed NSCLC not curable by surgery

- Karnofsky > 80%

- Tumor volume and localization allow curative radiotherapy

- Written consent

Exclusion Criteria:

- Metastases

- Diabetes

- Pregnancy

- Psychiatric impairment

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Joerg Kotzerke, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Nuclear Medicine

Authority:

Germany: Federal Office for Radiation Protection

Study ID:

BCA-FDG-FU

NCT ID:

NCT00180154

Start Date:

July 2005

Completion Date:

Related Keywords:

  • Lung Cancer
  • radiation therapy
  • F-18-FDG
  • NSCLC
  • Lung Neoplasms

Name

Location